[C 10 H17N5O], monoclinic, P21/c (no. 14), a = 8.12150(10) Å,
CrysAlis PRO [1] , SHELX [2, 3] , WinGX and ORTEP [4] Experimental details
The C-bound H atoms were geometrically placed (C-H = 0.99 Å) and refined as riding with U iso (H) = 1.2Ueq(C). The N-bound H-atoms were located in difference Fourier maps but were refined with a distance restraint of N-H = 0.88 ± 0.01 Å, and with U iso (H) set to 1.2U equiv (N).
Discussion
Interest in molecules related to the title compound stem from the significant biological activity exhibited by 1,2,4-triazoles [6, 7] . This interest prompts investigations into efficient synthesis of these derivatives and in this context, recently two new complementary pathways for the synthesis of N-substituted 3-(5-amino-1H-1,2,4-triazol-3-yl) propanamides based on microwave technology were described [5] . The title compound was one of the species prepared in that study and herein its crystal and molecular structures are described. The molecular structure of the title structure is shown in the Figure ( The observed tautomer is as expected based on literature precedents [8] . However, a compound was recently identified crystallizing with a hydrogen located at the nitrogen atom furthest away from the amino group, that is, existing in the form of the 3-amino-1H-tautomer [9] . It is also noted that an example of a crystal comprising both 5-amino-1H-and 3-amino-1H-tautomers, co-existing in equal proportions, has also been reported [10] . The most closely related structure in the literature is that of the derivative with an aniline residue connected to the carbonyl-C5 atom [5] . This molecule adopts the same tautomeric form as reported herein.
